Pearson AD - Search Results

1

Population pharmacokinetics of carboplatin in children.

Chatelut E, Boddy AV, Peng B, Rubie H, Lavit M, Dezeuze A, Pearson AD, Roché H, Robert A, Newell DR, Canal P. Chatelut E, et al. Among authors: pearson ad. Clin Pharmacol Ther. 1996 Apr;59(4):436-43. doi: 10.1016/S0009-9236(96)90113-7. Clin Pharmacol Ther. 1996. PMID: 8612389 Clinical Trial.

2

Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients.

Tasso MJ, Boddy AV, Price L, Wyllie RA, Pearson AD, Idle JR. Tasso MJ, et al. Among authors: pearson ad. Cancer Chemother Pharmacol. 1992;30(3):207-11. doi: 10.1007/BF00686313. Cancer Chemother Pharmacol. 1992. PMID: 1628369

3

Exposure and schedule dependency of etoposide in neuroblastoma and leukaemia cells in vitro.

Lowis SP, Newell DR, Pearson AD. Lowis SP, et al. Among authors: pearson ad. Eur J Cancer. 1995;31A(4):622-6. doi: 10.1016/0959-8049(95)00026-f. Eur J Cancer. 1995. PMID: 7576982

4

Comparison of continuous infusion and bolus administration of ifosfamide in children.

Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Boddy AV, et al. Among authors: pearson ad. Eur J Cancer. 1995;31A(5):785-90. doi: 10.1016/0959-8049(95)00090-6. Eur J Cancer. 1995. PMID: 7640054

5

The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion.

Boddy AV, Cole M, Pearson AD, Idle JR. Boddy AV, et al. Among authors: pearson ad. Cancer Chemother Pharmacol. 1995;36(1):53-60. doi: 10.1007/BF00685732. Cancer Chemother Pharmacol. 1995. PMID: 7720176

6

The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in paediatric patients: a review.

Bin P, Boddy AV, English MW, Pearson AD, Price L, Tilby MJ, Newell DR. Bin P, et al. Among authors: pearson ad. Anticancer Res. 1994 Nov-Dec;14(6A):2279-83. Anticancer Res. 1994. PMID: 7825959 Review.

7

Cyclophosphamide metabolism in children.

Yule SM, Boddy AV, Cole M, Price L, Wyllie R, Tasso MJ, Pearson AD, Idle JR. Yule SM, et al. Among authors: pearson ad. Cancer Res. 1995 Feb 15;55(4):803-9. Cancer Res. 1995. PMID: 7850793

8

Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.

Walker D, Flinois JP, Monkman SC, Beloc C, Boddy AV, Cholerton S, Daly AK, Lind MJ, Pearson AD, Beaune PH, et al. Walker D, et al. Among authors: pearson ad. Biochem Pharmacol. 1994 Mar 29;47(7):1157-63. doi: 10.1016/0006-2952(94)90387-5. Biochem Pharmacol. 1994. PMID: 8161344

9

Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group.

Newell DR, Pearson AD, Balmanno K, Price L, Wyllie RA, Keir M, Calvert AH, Lewis IJ, Pinkerton CR, Stevens MC. Newell DR, et al. Among authors: pearson ad. J Clin Oncol. 1993 Dec;11(12):2314-23. doi: 10.1200/JCO.1993.11.12.2314. J Clin Oncol. 1993. PMID: 8246021

10

Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children.

Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Boddy AV, et al. Among authors: pearson ad. Cancer Res. 1993 Aug 15;53(16):3758-64. Cancer Res. 1993. PMID: 8339288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page